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AutopsyCerebral venous sinus thrombosis (CVST) is an uncommon form of stroke, and mortality of the acute phase is
high. We report the clinical, postmortem 3 T-MRI, and autopsy features of a patient, 20-year-old Japanese
woman, with CVST who died shortly after starting to use low-dose estrogen combined hormonal contraceptives
(CHCs). A postmortem 3 T-MRI study with our originally developed system revealed abnormal intensities sug-
gestive of thrombi extending throughout the straight sinus and left sigmoid sinus. At autopsy, in accordance
with the images,we performed careful preparations of the sinuses. Histological examination revealed an organiz-
ingwhite thrombus occupying the lumen of the left sigmoid sinus, and an acute, red thrombus in the lumen of the
left transverse, straight, and tentorial sinuses, and vein of Galen, indicating that the thrombus had developed ﬁrst
in the left sigmoid sinus, then extended retrogradely to the more proximal portion of the sinus system, reaching
the vein of Galen. The features of the present CVST patient appear to be informative, when encountering CHC
users with neurological symptoms, even in those who begun to use low-dose estrogen CHCs only recently.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cerebral venous sinus thrombosis (CVST) is an uncommon form of
stroke, accounting for 0.5%–1.0% of all strokes [1]. The clinical manifes-
tations of CVST depend on the location of the thrombus, and may in-
clude headache, seizure, focal neurological symptoms, and
consciousness disturbance. CSVT is often associated with hemorrhagic
infarction in the thalamus and basal ganglia. Thereupon, mortality in
the acute phase is high, and ranging from 3% to 15%. CSVTmostly affects
youngwomen of childbearing age because they sometimes have several
risk factors, including pregnancy and use of oral contraceptives [2]. Re-
cent cohort studies have provided evidence that the relative risk of
thrombotic events associatedwith newly developed, low-dose estrogen
combined hormonal contraceptives (CHCs) may be lower than that
with conventional CHCs [3,4]. In Japan, low-dose estrogen CHCs wererain Research Institute, Niigata
Japan. Tel.: +81 25 2270673;
. This is an open access article underrecently approved for use. Therefore, for precise assessment of the risk
or safety of this drug for Japanese women, both a large-scale cohort
study and information on extraordinarily unexpected cases in this pop-
ulation would be useful.
Recently,we encountered a patientwith CVSTwhodied shortly after
starting to use low-dose estrogen CHCs. Here we report the clinical,
postmortem 3 T-MRI, and autopsy features of this patient.2. Case report
A 20-year-old Japanese woman with no signiﬁcant medical history
was prescribed an oral CHC tablet, drospirenone (3 mg)/ethinyl estradi-
ol (20 μg) (YAZ®), for dysmenorrhea. In a few days after starting to take
the CHC, she developed a headache. On the 9th day of CHC use, her
headache worsened and she experienced nausea, appetite loss, and dif-
ﬁculty in walking: therefore she discontinued taking the CHC. In the af-
ternoon of the following day, she was conﬁned to bed, and next early
morning, on the 11th day after starting to take the CHC, she was
found unconscious and rushed to a hospital. A brain CT and MRI study
revealed infarcts with edema in the bilateral thalami and left cerebellarthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Axial MRI (A, B), sagittal CT (C), and CT venography (D) images of the patient taken on admission to hospital. Lesions with edema in the bilateral thalami (A) and left cerebellar
hemisphere (B) appearing hyperintense on the ﬂuid-attenuated inversion recovery (FLAIR) image. A mid-line lipoma (arrowhead in A). (C) A large thrombus in the vein of Galen and
straight sinus (arrow). Hypointense lesion (arrowhead in C), suspicious of pericallosal lipoma, is evident. (D) Absence of ﬂow in the straight (arrow) and left transverse (arrowhead) sinus.
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she was transferred immediately to Niigata University Hospital. On ad-
mission, the patient was suffering from generalized convulsions and
was administered diazepam. She then became comatose and quadriple-
gic. A CT scan disclosed a large thrombus in the vein of Galen and
straight sinus (Fig. 1C), and CT venography clearly demonstrated ab-
sence of ﬂow in the vein of Galen, straight sinus, and left transverse
and sigmoid sinus (Fig. 1D), leading to a diagnosis of CSVT. A serological
examination demonstrated a low level of hemoglobin (7.3 g/dL), and an
elevated D-dimer level (6.8 μg/mL), but the titers of several autoanti-
bodies, including antinuclear, anti-cardiolipin, and anti-β2-
glycoprotein I were normal. Despite administration of anticoagulants
shortly after admission, on the second day she developed respiratory
failure and required artiﬁcial respirator support thereafter. She died
on the third day.
Written informed consent for postmortem imaging and autopsy,
and subsequent use of the images and tissue samples for research pur-
poses was obtained from her parents. We performed a postmortem
MRI study with our originally developed system. Brieﬂy, the body was
packed in a sealable polyethylene bag, and placed supine in a polycar-
bonate cofﬁn, which was maintained at 7.5–8.5 °C with circulating
cooled dry air. The whole body within the cofﬁn was imaged with a
SIGNA 3 T MRI (GE Healthcare, Waukesha, WI, USA) using a body coil.
Acquisition of the head was performed using a T1-weighted (T1W)
image (axial—TSE, TE 3.2 ms, TR 7.5 ms, 1.5-mm thickness) and a T2Wimage (axial—TSE, TE 81.0ms, TR 4000ms, 4.0-mmthickness), followed
by T2W imaging of the neck, abdomen, thighs, and legs. The total acqui-
sition time was about 7 h. Consistent with the antemortem images
(Fig. 1), hemorrhagic or anemic infarcts and edema in the bilateral thal-
ami and left cerebellar hemisphere (Fig. 2A and B), and abnormal inten-
sities suggestive of thrombi extending throughout the straight sinus
(Fig. 2H and I) and left sigmoid sinus (Fig. 2N and O) were evident. No
thrombus was observed in the right sigmoid sinus (Fig. 2T and U),
body or extremities.
A general autopsy was performed. The fresh brain was severely
swollen and soft. Fresh hemorrhagic or anemic infarcts involving
the bilateral thalami, midbrain tegmentum and base on the left
side, and the left cerebellar hemisphere, were conﬁrmed. In accor-
dance with the postmortem images, we performed careful prepara-
tion of the sinuses and found that a continuous thrombotic
substance occupied the lumen of the vein of Galen, and straight,
tentorial, left transverse, and left sigmoid sinuses (Fig. 2C-E). Histo-
logical examination revealed an organizing white thrombus occupy-
ing the lumen and involving the wall of the left sigmoid sinus (Fig. 2P
and Q), and an acute, red thrombus in the lumen of the left trans-
verse, straight, and tentorial sinuses, and vein of Galen (Fig. 2J and
K), indicating that the thrombus had developed ﬁrst in the left sig-
moid sinus, then extended retrogradely to the more proximal por-
tion of the sinus system, reaching the vein of Galen. No thrombus
was evident in the right transverse sinus.
Fig. 2.MRI and autopsy ﬁndings. T1-weighted (T1W) (A, F, H, L, N, R, T) and T2W(B, G, I,M, O, S, U) images of post-mortem 3 TMRI (A, B, H, I, N, O, T, U) and ante-mortem1.5 TMRI (F, G, L,
M, R, S). The gross appearance (C–E), cut surface (J, P), and histology images of the sinuses (K, Q). Images of the straight (F-K: arrowheads in F-I), left sigmoid (L-Q: arrowheads in L-O), and
right sigmoid (R-U: arrowheads) sinuses. Arrowhead in B indicates the left sigmoid sinus. Arrowhead and arrows in C indicate the vein of the left tentorium cerebelli and straight sinus,
respectively. Arrows in D and E indicate the left transverse sinus and vein of Galen, respectively. Note the difference in signal intensity between the ante- and postmortem MRI. In the
straight sinus, the thrombus shows low (F) and high (H) intensity on T1W images, respectively, and similar low intensity (G, I) on T2W images, representing the red thrombus (J, K).
In the left sigmoid sinus, the thrombus shows high (L) and heterogeneously low (N) intensity on T1W images, respectively, and high (M) and heterogeneously high (O) intensity on
T2W images, respectively, representing the white thrombus (P, Q). (V) A schematic representation of temporal extension of the thrombus (yellow: old, white thrombus, red: relatively
fresh, red thrombus). The long, curved arrow indicates retrograde extension of the thrombus within the sinus system.
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3.0 T-MRI, histopathologic pictures of the corresponding sinuses, and a
schematic representation of the sinus thrombosis are shown in
Fig. 2F–V.3. Discussion
In the present study, we demonstrated the features of the sinus
thrombosis in detail using our originally developed postmortem 3 T-
35M. Uemura et al. / Human Pathology: Case Reports 6 (2016) 32–36MRI system, and then investigated the corresponding lesions in histo-
pathologic preparations (Fig. 2).
The patient had acute symptoms possibly associated with the devel-
opment of thrombus shortly after starting to take the CHC. In general,
venous thrombosis tends to develop inwomenwhohave used oral con-
traceptives for a prolonged period [4]. However, a population-based,
case–control study revealed that women who use oral contraceptives,
and who have inherited clotting defects (deﬁciencies of protein C, pro-
tein S, or antithrombin, or otherwise mutations of factor V Leiden or
prothrombin 20,210A)may develop venous thrombus signiﬁcantly ear-
lier than those without such defects [5]. Considering the fact that this
patient developed sinus thrombosis immediately after starting to take
the CHC, she may have had certain underlying risk factors, even though
no such factors were apparent, as described above. We were unable to
perform further examinations of other coagulation factors, including
protein C, protein S, or antithrombin III, in view of the patient's serious
condition. In response to three lethal cases of thrombosis, including
the present one, in women taking YAZ® in Japan as of January 2014,
theMinistry of Health, Labor andWelfare has issued safety communica-
tion about the risk of thrombosis associated with the use of YAZ® com-
bination tablets for dysmenorrhea [6].
We speculated that the thrombushad initially developed in the left sig-
moid sinus and extended retrogradely (Fig. 2V). Hemorrhagic infarcts in
the bilateral thalami appeared to have developed when the thrombus
reached the straight sinus. In the present study, we successfully demon-
strated alterations in the MRI signal intensity of the sinus thrombus
(Fig. 2), reﬂecting thephasesof thrombusorganization [7,8]. In the straight
sinus, the thrombus showed low (Fig. 2F) and high (Fig. 2H) intensity in
T1W ante- and post-mortem images, respectively, indicating that the
thrombus was fresh. On the other hand, in the left sigmoid sinus, the
thrombus demonstrated high (Fig. 2L) and heterogeneously low
(Fig. 2N) intensity in the ante- and post-mortem T1W images, respective-
ly, indicating that the thrombus was relatively well organized. These im-
ages seemed to be consistent with the histopathologic features (Fig. 2J,
K, P and Q), and supported the idea of thrombus extension (Fig. 2V).
As demonstrated in the present study, our postmortem 3 T MRI sys-
tem is practically useful for detection of brain lesions. This system can
keep the whole body in a refrigerated state during the long acquisition
time required. Following MRI, we performed a complete autopsy. This
reﬂects our policy of combining both high-resolution imaging and pa-
thology studies in order to gain a better understanding of the patho-
physiology in individual cases. To our knowledge, another
postmortem 3 T MRI system mainly targeting cardiopulmonary disor-
ders has been reported in Switzerland [9].
It is unclearwhether thewhite thrombus developed after the patient
had begun to take the CHC, or whether it had already been present. Thepatient had no medical history that suggested she might be at risk of
CVST. Moreover, histological examination revealed that the proximal
portion of the thrombus in the left sigmoid sinus contained an admix-
ture of both organizing and fresh thrombi (images not shown), suggest-
ing temporal continuity of thrombus organization. The diameter of the
left transverse and sigmoid sinuses appeared much smaller than that
of the right sinus. Therefore, the main venous ﬂow may have been
through the right sinus, and if so, such hemodynamics could have
posed a risk of CVST in the left sigmoid sinus.
In the present patient, a lipoma on the body of the corpus callosum
was evident (Fig. 1C). To our knowledge, there is no evidence indicating
a close association between the presence of lipoma and development of
CSVT.
The clinical, postmortem 3 T-MRI, and autopsy features of the pres-
ent patient appear to be informative. When encountering patients with
headache and other symptoms suggestive of increased intracranial
pressure, even in those who have begun to use low-dose estrogen
CHCs only recently, andwhile recognizing that such cases are rare, care-
ful follow-up, including MRI of the sinus system, should be conducted
for accurate and prompt diagnosis of CSVT. If applicable, further surgical
intravascular approaches may be considered for such patients.
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